Epogen

This page contains recent news articles, when available, and an overview of Epogen but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

News: Epogen

Book Review Monday: Gray Markets: Prevention, Detection, and Litigation  -  23 Nov 2009
Patent Baristas (blog)Fagan suffered personal injuries as a result of repeated injection of counterfeit Epogen used to treat anemia. Fagan continued to receive and inject ...

Aranesp, Epogen and Procrit Blood Clot Risk Confirmed: Study  -  ‎Nov 11, 2009‎
AboutLawsuits.comAccording to new research, the anti-anemia drugs Aranesp, Epogen and Procrit not only increase the risk of blood clots, but they also do not appear to be ...

Amgen's Anemic Results  -  ‎Oct 30, 2009‎
ForbesWhen the trial began years ago, convictions were so high that Epogen, Aranesp and other red blood cell boosters would lower death rates in kidney patients ...

Hematide To Pose Threat to AMGN's Base Business From Late 2011  -  ‎Nov 20, 2009‎
BenzingaAccording to Citi, the market has overlooked competition to Amgen's Epogen and Aranesp from Hematide. Citi expects this drug to pose threat to AMGN's base ...

Drug counterfeiters bank on peoples' fear of flu  -  ‎Nov 15, 2009‎
NewsdayHis bill is named for Tim Fagan, a Deer Park teenager who nearly died in 2002 after being injected with a counterfeit version of the immune booster, Epogen, ...

Trish and Curtis Selver respond to reports about Kidney Foundation  -  ‎Nov 17, 2009‎
Turks and Caicos SunTo date the foundation has spent $22000 on Epogen. As reported in the news, patient care at the Stephanie Williams Kidney Centre is slipping and it recently ...

PRIMECAP Management Top Holdings: Amgen Inc., Eli Lilly and Company, Novartis ...  -  ‎Nov 22, 2009‎
GuruFocus.comAranesp and EPOGEN stimulate the production of red blood cells to treat anemia and belong to a class of drugs referred to as erythropoiesis-stimulating ...

Increased Chance Of Stroke With Anemia Medications?  -  ‎Nov 2, 2009‎
RedOrbitIn the last two years, the Food and Drug Administration has reinforced their warnings over Aranesp, Epogen and Procrit bottles as concerns have arisen that ...

Profiteers peddling flu vaccine  -  ‎Nov 7, 2009‎
Cape Cod TimesTurkewitz represented a teenaged liver transplant patient, Tim Fagan, who was injected with a counterfeit version of a drug called Epogen in 2002. ...

ASN: Comorbidities Determine Effects of Raising Hemoglobin  -  ‎Nov 3, 2009‎
MedPage TodayThe primary CHOIR results found that treating anemic patients who were not on dialysis with epoetin-alfa (Epogen, Procrit) to achieve a target hemoglobin of ...

Aranesp Suit: What Did Amgen CEO Sharer Know (and Did He Read It in His ...  -  ‎Nov 2, 2009‎
BNETThe email indicates that the information — which describes how Epogen's overfills were reduced when Aranesp hit the market — was to be delivered to Sharer. ...

Dialysis patients in jeopardy  -  ‎Nov 2, 2009‎
Turks and Caicos Sun...“Sometime ago, Pastor Coleta church (Abundant Life Ministries International) donated $5000 to buy Epogen - a glycoprotein hormone that controls red blood ...

Affymax: Hematide comparable to Epogen in trial  -  ‎Oct 30, 2009‎
Reuters IndiaResults from four pivotal-stage trials comparing Hematide to Epogen or once-weekly Aranesp, both sold by Amgen Inc (AMGN.O: Quote, Profile, Research), ...

Amgen's troubles keep compounding; Aranesp studies reveal greater risks  -  ‎Nov 11, 2009‎
Daily Finance (blog)Amgen's drug Epogen and Johnson & Johnson's (JNJ) Procrit belong to the same family of drugs, called erythropoiesis-stimulating agents (ESAs). ...

Nearly Half of Dialysis Clinics Do Not Specify Hemoglobin Range  -  ‎Nov 10, 2009‎
Renal Business TodayNearly all end-stage renal disease patients have anemia, which can be treated with erythropoietin-stimulating agents—such as Amgen's Epogen and Aranesp or ...

1500-meter 2008 Olympic gold medalist caught cheating  -  ‎Nov 18, 2009‎
Examiner.comAlthough the synthetically produced EPO, Epogen® (Epoetin alfa), serves the medical purpose of treating anemia, it enhances athletic performance and is ...

How Similar Are Biosimilars?  -  ‎Nov 18, 2009‎
Forbes...erythropoietin), a supposedly identical version of a sibling called Epogen (which was manufactured in a different facility), caused a 30-fold increase ...

Band-Aid Won't Stop Generic Bleeding at Johnson & Johnson  -  ‎Nov 11, 2009‎
BNET...like Amgen's Epogen or Aranesp — have opinion leaders opining that risks possibly outweigh perceived benefits in oncology patients. ...

Amgen suit unveils industry 'overfilling' practices  -  ‎Nov 10, 2009‎
Trading Markets (press release)It went on to state that, around the time it launched Aranesp, Amgen started lowering the overfill amounts in Epogen, its earlier anemia drug, and Procrit, ...

New president for Kidney Foundation  -  ‎Nov 13, 2009‎
Turks and Caicos Weekly News...and Grand Turk patients, and over the last year, stepping in, when funds were available, to purchase the expensive but essential kidney drug Epogen. ...

Estudio: Riesgo de apoplejía por fármaco contra la anemia  -  ‎Oct 31, 2009‎
Houston ChronicleAlimentos de Estados Unidos (FDA) ha reforzado repetidamente las etiquetas de advertencia en el exterior de los medicamentos Aranesp, Epogen y Procrit, ...

Μελέτη επιβεβαιώνει τον κίνδυνο θ?όμβωσης από τις ε?υθ?οποιητίνες  -  ‎Nov 15, 2009‎
Healthviewκαι οδήγησαν σε κατακό?υφη πτώση των πωλήσεων των εν λόγω φα?μάκων, όπως των Aranesp και Epogen της Amgen και του Procrit της Johnson & Johnson. ...

조혈 ?극제 빈혈약, 혈전 ?성 위험 2배 높여  -  ‎Nov 10, 2009‎
데일리팜...대??? 조혈?극제로는 암젠? '아?네스프(Aranesp)'와 '???(Epogen)', J&J? '프로?리트(Procrit)'가 있다. 지난 2006년 J&J? ?한 연구결과 조혈?극제를 ...

Dialysecentra VS negeren waarschuwingen EPO-gebruik  -  ‎Nov 11, 2009‎
NierNieuws.nl...de praktijk niet in overeenstemming zou zijn met de waarschuwingen voor de toepassing van Epogen en Aranesp van Amgen en Procrit van Johnson & Johnson. ...

סכנה לקרישי ד? משימוש בתרופות ל?נמיה  -  ‎Nov 11, 2009‎
News1 מחלקה ראשונה...מכירות התרופות, כולל ?רנספ (Aranesp) ו?פוגן (Epogen) של ?מגן, ופרוקריט (Procrit) של ג'ונסון ג'ונסון ירדו בצורה חדה מ?ז שמחקר שנעשה על-ידי ג'ונסון ג'ונסון ...

Amgen kaufen  -  ‎Nov 13, 2009‎
AktienCheckDas Nachfolgepräparat von Epogen (gegen Blutarmut), Aranesp, habe schlechte klinische Daten gebracht, die den Aktienkurs kurzfristig schwächer habe ...

Pure Red-Cell-Aplasie: Rezeptoragonist überwindet Epo-Resistenz  -  ‎Nov 5, 2009‎
Deutsches ÄrzteblattFast alle waren zuvor mit dem Präparat Eprex® (einige auch mit Epogen® oder NeoRecormon®) behandelt worden, die damals üblicherweise subkutan appliziert ...



Background information on Epogen [When available]

Biological therapy is a type of treatment that works with your immune system. It can help fight cancer or help control side effects (how your body reacts to the drugs you are taking) from other cancer treatments like chemotherapy.

What is the difference between biological therapy and chemotherapy?

Biological therapy and chemotherapy are both treatments that fight cancer. While they may seem alike, they work in different ways. Biological therapy helps your immune system fight cancer. Chemotherapy attacks the cancer cells directly.

How does biological therapy fight cancer?

Doctors are not sure how biological therapy helps your immune system fight cancer. But they think it may:
  • Stop or slow the growth of cancer cells.
  • Make it easier for your immune system to destroy, or get rid of, cancer cells.
  • Keep cancer from spreading to other parts of your body.
More from the National Cancer Institute

Search the web for more resources on Epogen



Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy